BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Statistics

Total Valuation

BVMF:B1ME34 has a market cap or net worth of BRL 221.21 billion. The enterprise value is 205.73 billion.

Market Cap	221.21B
Enterprise Value	205.73B

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+7.42%
Shares Change (QoQ)	+4.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.79M

Valuation Ratios

The trailing PE ratio is 1,257.80 and the forward PE ratio is 82.48.

PE Ratio	1,257.80
Forward PE	82.48
PS Ratio	8.30
PB Ratio	10.07
P/TBV Ratio	10.52
P/FCF Ratio	84.72
P/OCF Ratio	57.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 101.39, with an EV/FCF ratio of 78.80.

EV / Earnings	1,169.79
EV / Sales	7.77
EV / EBITDA	101.39
EV / EBIT	221.31
EV / FCF	78.80

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.28.

Current Ratio	2.40
Quick Ratio	2.11
Debt / Equity	0.28
Debt / EBITDA	2.97
Debt / FCF	2.38
Interest Coverage	12.61

Financial Efficiency

Return on equity (ROE) is 0.88% and return on invested capital (ROIC) is 2.39%.

Return on Equity (ROE)	0.88%
Return on Assets (ROA)	1.74%
Return on Invested Capital (ROIC)	2.39%
Return on Capital Employed (ROCE)	3.54%
Revenue Per Employee	2.42M
Profits Per Employee	15,988
Employee Count	11,000
Asset Turnover	0.75
Inventory Turnover	1.43

Taxes

In the past 12 months, BVMF:B1ME34 has paid 692.53 million in taxes.

Income Tax	692.53M
Effective Tax Rate	79.75%

Stock Price Statistics

The stock price has increased by +37.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.85%
50-Day Moving Average	60.34
200-Day Moving Average	45.49
Relative Strength Index (RSI)	53.17
Average Volume (20 Days)	144

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BVMF:B1ME34 had revenue of BRL 26.64 billion and earned 175.87 million in profits. Earnings per share was 1.57.

Revenue	26.64B
Gross Profit	22.99B
Operating Income	990.24M
Pretax Income	868.40M
Net Income	175.87M
EBITDA	1.78B
EBIT	990.24M
Earnings Per Share (EPS)	1.57

Balance Sheet

The company has 21.80 billion in cash and 6.23 billion in debt, giving a net cash position of 15.58 billion.

Cash & Cash Equivalents	21.80B
Total Debt	6.23B
Net Cash	15.58B
Net Cash Per Share	n/a
Equity (Book Value)	21.96B
Book Value Per Share	198.51
Working Capital	17.50B

Cash Flow

In the last 12 months, operating cash flow was 3.83 billion and capital expenditures -1.22 billion, giving a free cash flow of 2.61 billion.

Operating Cash Flow	3.83B
Capital Expenditures	-1.22B
Free Cash Flow	2.61B
FCF Per Share	n/a

Margins

Gross margin is 86.29%, with operating and profit margins of 3.72% and 0.66%.

Gross Margin	86.29%
Operating Margin	3.72%
Pretax Margin	3.26%
Profit Margin	0.66%
EBITDA Margin	6.68%
EBIT Margin	3.72%
FCF Margin	9.80%

Dividends & Yields

BVMF:B1ME34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	72.48%
Buyback Yield	-7.42%
Shareholder Yield	-7.42%
Earnings Yield	0.08%
FCF Yield	1.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	8